For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Unified and strong voices key to future of primary care
Wednesday 10 April 2024, 12:00 AM

GPNZ is evolving, but its purpose remains the same: The pursuit of equitable health outcomes for all New Zealanders [Image: Clay Banks on Unsplash]
Its name might be changing, but GPNZ’s commitment to partnership, equity and Te Tiriti principles is resolute, writes Bryan Betty
Collectively, we are in a better, more united place, which is essential as we head back to the PSAAP table
We are currently moving through the ne
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.